Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (311-320 of 587) with videos related to

Pageof 59
Sort By:
Eclinicalmedicine|November 22, 2021
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator PB-201 and its effects on the glucose excursion profile in drug-naïve Chinese patients with type 2 diabetes: a randomised controlled, crossover, single-centre phase 1 trialDongyang Liu, Ying Du, Xueting Yao, et al.
Journal of Diabetes|June 10, 2014
Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: subgroup analysis of the SOLVE studyChangyu Pan, Ping Han, Linong Ji, et al.
Cardiovascular Diabetology|October 1, 2025
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional studyWenfeng Yang, Chu Lin, Xiaoling Cai, et al.
Diabetes, Obesity & Metabolism|May 31, 2026
Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II TrialPing Jin, Linong Ji, Yangqing Huang, et al.
Diabetes, Obesity & Metabolism|October 22, 2024
Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trialLeili Gao, Fang Bian, Tianrong Pan, et al.
Plos One|February 23, 2013
Rs4074134 near BDNF gene is associated with type 2 diabetes mellitus in Chinese Han population independently of body mass indexXueyao Han, Yingying Luo, Xiuying Zhang, et al.
Advances in Therapy|April 21, 2019
Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study)LiNong Ji, LiMing Chen, YanGang Wang, et al.
BMC Health Services Research|April 28, 2018
The association between insurance coverage for insulin pen needles and healthcare resource utilization among insulin-dependent patients with diabetes in ChinaLinong Ji, Arthi Chandran, Timothy J Inocencio, et al.
ESC Heart Failure|October 25, 2023
Dapagliflozin treatment and cardiovascular outcome in RBP4/TTR<sup>Val30Met</sup> (transthyretin cardiac amyloidosis) miceZonglin Li, Fang Lv, Xin Wen, et al.
Molecular and Cellular Endocrinology|April 12, 2016
Brain derived neurotrophic factor in newly diagnosed diabetes and prediabetesWei Liu, Xueyao Han, Xianghai Zhou, et al.
Pageof 59

Showing results (311-320 of 587) with videos related to

Sort By:
Pageof 59
Eclinicalmedicine|November 22, 2021
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator PB-201 and its effects on the glucose excursion profile in drug-naïve Chinese patients with type 2 diabetes: a randomised controlled, crossover, single-centre phase 1 trialDongyang Liu, Ying Du, Xueting Yao, et al.
Journal of Diabetes|June 10, 2014
Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: subgroup analysis of the SOLVE studyChangyu Pan, Ping Han, Linong Ji, et al.
Cardiovascular Diabetology|October 1, 2025
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional studyWenfeng Yang, Chu Lin, Xiaoling Cai, et al.
Diabetes, Obesity & Metabolism|May 31, 2026
Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II TrialPing Jin, Linong Ji, Yangqing Huang, et al.
Diabetes, Obesity & Metabolism|October 22, 2024
Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trialLeili Gao, Fang Bian, Tianrong Pan, et al.
Plos One|February 23, 2013
Rs4074134 near BDNF gene is associated with type 2 diabetes mellitus in Chinese Han population independently of body mass indexXueyao Han, Yingying Luo, Xiuying Zhang, et al.
Advances in Therapy|April 21, 2019
Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study)LiNong Ji, LiMing Chen, YanGang Wang, et al.
BMC Health Services Research|April 28, 2018
The association between insurance coverage for insulin pen needles and healthcare resource utilization among insulin-dependent patients with diabetes in ChinaLinong Ji, Arthi Chandran, Timothy J Inocencio, et al.
ESC Heart Failure|October 25, 2023
Dapagliflozin treatment and cardiovascular outcome in RBP4/TTR<sup>Val30Met</sup> (transthyretin cardiac amyloidosis) miceZonglin Li, Fang Lv, Xin Wen, et al.
Molecular and Cellular Endocrinology|April 12, 2016
Brain derived neurotrophic factor in newly diagnosed diabetes and prediabetesWei Liu, Xueyao Han, Xianghai Zhou, et al.
Pageof 59